Get the Stockscreener App
0.00
100.00%
-1.26
Sonnet Biotherapeutics Holdings Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$1.26
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$8.60M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
0.00
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Name
Sonnet Biotherapeutics Holdings Inc
Sector
Industry
Phone
609-375-2227
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
0.00 | 8.60M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News
Aug Reactions: Does Sonnet BioTherapeutics Holdings Inc align with a passive investing strategy2025 Buyback Activity & Daily Entry Point Alerts - baoquankhu1.vn
Aug Outlook: Is Sonnet BioTherapeutics Holdings Inc stock a good dividend stock2025 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Ideas: What makes AIFU stock attractive todayMarket Activity Summary & Weekly High Potential Stock Alerts - baoquankhu1.vn
Can Sonnet BioTherapeutics Holdings Inc. stock continue upward trendJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - mfd.ru
Why Sonnet BioTherapeutics Holdings Inc. stock attracts global investors2025 Dividend Review & Low Risk Investment Opportunities - mfd.ru
Why Sonnet BioTherapeutics Holdings Inc. stock is considered a top pickJuly 2025 Update & Advanced Swing Trade Entry Alerts - mfd.ru
Does Sonnet BioTherapeutics Holdings Inc. align with a passive investing strategy2025 Macro Impact & Fast Moving Trade Plans - mfd.ru
What’s the outlook for Sonnet BioTherapeutics Holdings Inc.’s sectorJobs Report & Technical Analysis for Trade Confirmation - mfd.ru
Hyperliquid Strategies posts $318 million net loss on $262 million unrealized HYPE losses - The Block
What’s the MACD signal for Sonnet BioTherapeutics Holdings Inc.Portfolio Risk Report & Expert Verified Stock Movement Alerts - mfd.ru
Published on: 2026-02-08 12:03:59 - baoquankhu1.vn
What is the next catalyst for Sonnet BioTherapeutics Holdings IncMarket Trend Report & Community Consensus Picks - baoquankhu1.vn
Chart Watch: Whats the outlook for Sonnet BioTherapeutics Holdings Incs sector2025 Buyback Activity & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Sonnet BioTherapeutics Adjourns Meeting for Business Combination - MSN
Aug Decliners: Should I invest in Sonnet BioTherapeutics Holdings Inc before earningsJuly 2025 Breakouts & Low Drawdown Investment Strategies - baoquankhu1.vn
Quarterly Trades: Whats the outlook for Sonnet BioTherapeutics Holdings Incs sectorStop Loss & Reliable Breakout Forecasts - baoquankhu1.vn
Bear Alert: What is the target price for Sonnet BioTherapeutics Holdings Inc stock2025 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Risk Recap: Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryInflation Watch & Short-Term High Return Strategies - Bộ Nội Vụ
Growth Value: Should I average down on Sonnet BioTherapeutics Holdings Inc stock2025 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Published on: 2026-01-13 09:37:35 - baoquankhu1.vn
Published on: 2026-01-12 20:21:52 - baoquankhu1.vn
Is Sonnet BioTherapeutics Holdings Inc. stock a defensive play in 2025Earnings Recap Report & Consistent Profit Trade Alerts - Улправда
Should I hold or sell Sonnet BioTherapeutics Holdings Inc. stock in 2025Quarterly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for income investorsGold Moves & Free Expert Verified Stock Movement Alerts - Улправда
Is Sonnet BioTherapeutics Holdings Inc. stock vulnerable to regulatory risksChart Signals & Free Long-Term Investment Growth Plans - Улправда
Why Sonnet BioTherapeutics Holdings Inc. stock is a must watch in 2025Value Traps to Avoid & Build Wealth With Strategy - ulpravda.ru
Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryMarket Insider Reports & Budget Friendly Portfolio - Улправда
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - MSN
Ideas Watch: Should I hold or sell Sonnet BioTherapeutics Holdings Inc stock in 2025Weekly Profit Summary & Community Trade Idea Sharing Platform - moha.gov.vn
Breakout Move: Will Sonnet BioTherapeutics Holdings Inc stock benefit from automationEarnings Growth Summary & Verified Momentum Stock Ideas - moha.gov.vn
Head to Head Comparison: Sonnet BioTherapeutics (NASDAQ:SONN) & BioXcel Therapeutics (NASDAQ:BTAI) - Defense World
Will Sonnet BioTherapeutics Holdings Inc. stock deliver better than expected guidanceBear Alert & Free Verified High Yield Trade Plans - Улправда
Will Sonnet BioTherapeutics Holdings Inc. stock benefit from automationJuly 2025 Earnings & AI Optimized Trading Strategy Guides - DonanımHaber
Will Sonnet BioTherapeutics Holdings Inc. stock maintain growth storyTrade Signal Summary & Real-Time Market Sentiment Reports - DonanımHaber
Sonnet BioTherapeutics (NASDAQ: SONN) updates FHAB-based oncology pipeline - Stock Titan
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing - Stock Titan
Sonnet BioTherapeutics Holdings: Net loss of $16.0M on $1.0M revenue, with urgent need for new funding to sustain operations - TradingView — Track All Markets
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Down 67.3% – Here’s Why - Defense World
What analysts say about Sonnet BioTherapeutics Holdings Inc stockMarket Timing Techniques & Low Cost Wealth Building - earlytimes.in
Lowenstein Represents Sonnet BioTherapeutics In Closing Of Business Combination With Hyperliquid Strategies - Mondaq
Officer Kenney Acquires 233,374 Of Sonnet BioTherapeutics Holdings Inc [SONN] - TradingView
Hyperliquid Strategies Moves $411M in HYPE to Hypercore - Live Bitcoin News
Will HYPE extend rally as Hyperliquid Strategies Inc. begins staking? - FXStreet
Sonnet BioTherapeutics Stockholders Greenlight Hyperliquid Strategies Merger Deal - Blockonomi
Sonnet’s $1B Hype Treasury Signals Ambitious Digital Asset Expansion After Merger Approval - Crypto Economy
Sonnet BioTherapeutics Merges with Hyperliquid Strategies - TipRanks
Biotech Trio Gets Hammered On Heavy Trading - Finimize
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for hedge fundsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Merges Into Hyperliquid Era with Nasdaq Debut as PURR - parameter.io
Sonnet BioTherapeutics Enters a New Frontier with a $1 Billion HYPE Digital Asset Treasury - OneSafe
Sonnet BioTherapeutics shareholders approve proposed business merger with Hyperliquid Strategies Inc. - Bitget
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):